RF cannulae market seen reaching $0.57 billion by 2030

The global radiofrequency cannulae market is projected to climb from $0.32 billion in 2025 to $0.57 billion by 2030, driven by demand for minimally invasive pain procedures and precision nerve ablation tools. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - The RF cannulae market is tied to the broader shift toward minimally invasive pain treatment. - Growth in this category reflects rising demand for faster recovery, lower complication risk and more precise nerve ablation. - The market’s expansion signals continued investment in specialty pain care infrastructure and disposable medical devices.

What happened: - The Business Research Company’s Global Market Report 2026 estimates the RF cannulae market at $0.32 billion in 2025. - The market is forecast to reach $0.36 billion in 2026, then rise to $0.57 billion by 2030. - The report projects a 12.0% CAGR from 2025 to 2026 and a 12.3% CAGR through 2030. - The report was published in London on Sept. 15, 2026. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company offers a free sample of the market report and the full market report.

The details: - Radiofrequency cannulae are specialized medical devices used to deliver controlled RF energy to targeted tissue during therapeutic or diagnostic procedures. - The devices create thermal lesions or modulate nerves and soft tissues. - The report cites rising chronic pain cases, early adoption of basic RF lesioning techniques, limited availability of advanced cannula designs, growth in interventional pain management practices and more hospital-based pain treatment centers as past growth drivers. - Future growth is linked to outpatient minimally invasive procedures, precision nerve ablation technologies, disposable and safer devices, specialty pain clinics in emerging markets and ergonomic insulated cannula improvements. - RF cannulae are designed for accuracy, biocompatibility and controlled energy delivery. - The devices are used in interventional pain management and other clinical fields. - Increasing preference for minimally invasive medical procedures is a major demand driver because these procedures reduce tissue trauma, pain, recovery time and infection risk. - Data from the American Society of Plastic Surgeons showed minimally invasive procedures increased 7% in 2023, outpacing traditional surgeries by 2%. - In 2025, North America held the largest share of the market. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Between the lines: - The forecast points to a market that is moving from basic lesioning tools toward more specialized, safer and more ergonomic products. - Strong growth in outpatient care suggests purchasing decisions may increasingly favor devices that support shorter procedures and quicker turnover. - The regional split suggests mature demand in North America and more room for expansion in emerging Asian markets.

What's next: - The market is likely to keep benefiting from the broader migration away from open surgery and toward image-guided, minimally invasive interventions. - Product development will likely center on safer disposables, tighter targeting and improved handling for clinicians. - Specialty pain clinics and hospital pain centers should remain key demand channels as chronic pain treatment volume rises.

The bottom line: - RF cannulae are becoming a more important tool in pain management, and the market’s projected rise to $0.57 billion by 2030 suggests steady demand for precision minimally invasive devices.